US 9303080
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
granted A61PA61P35/00A61P37/02
Quick answer
US patent 9303080 (Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells) held by The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer
- Grant date
- Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P35/00, A61P37/02